IQVIA Holdings Inc
Research IQVIA Holdings Inc (IQV) on Bullrun: valuation model: 15.8% overvalued, market cap USD 42.70B, P/E 32.2. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerIQV
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Valuation signal15.8% overvalued
- Market capUSD 42.70B
- P/E32.2
- Financial periodQ2 2026
- RevenueUSD 4.37B
- Net incomeUSD 256.00M
- Free cash flowUSD 360.00M
- Gross margin32.9%
Valuation Snapshot
Bullrun's latest valuation model marks IQVIA Holdings Inc as 15.8% overvalued; latest market cap is USD 42.70B; P/E is 32.2.
Peer valuation comparison
Latest P/E is 32.18x versus a Healthcare sector median of 24.46x (31.6% above).
Latest P/E is 32.18x versus a United States median of 24.87x (29.4% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 16.31B | USD 1.36B | USD 2.05B | 33.3% | 7.84 | USD 1.98B | USD 15.72B | USD 6.50B |
| FY2024 | USD 15.41B | USD 1.37B | USD 2.11B | 34.9% | 7.49 | USD 1.70B | USD 13.98B | USD 6.07B |
| FY2023 | USD 14.98B | USD 1.36B | USD 1.50B | 35.0% | 7.29 | USD 1.38B | USD 13.67B | USD 6.11B |
| FY2022 | USD 14.41B | USD 1.09B | USD 1.59B | n/a | 5.72 | USD 1.22B | USD 12.75B | USD 5.77B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 42.70B | 32.2 | n/a | n/a |
| 2025 | 2025-12-31 | USD 38.23B | 28.7 | n/a | n/a |
| 2024 | 2024-12-31 | USD 34.61B | 26.2 | n/a | n/a |
| 2023 | 2023-12-29 | USD 42.23B | 38.8 | n/a | n/a |
| 2022 | 2022-12-30 | USD 38.06B | 33.3 | n/a | n/a |
| 2021 | 2021-12-31 | USD 53.78B | 57.0 | n/a | n/a |
About IQVIA Holdings Inc
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is IQVIA Holdings Inc overvalued or undervalued?
Bullrun's valuation model currently marks IQVIA Holdings Inc as 15.8% overvalued.
What is IQVIA Holdings Inc's market cap?
IQVIA Holdings Inc's market capitalization is USD 42.70B.
What is IQVIA Holdings Inc's P/E ratio?
IQVIA Holdings Inc's price-to-earnings (P/E) ratio is 32.2.
What does IQVIA Holdings Inc do?
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.